<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Sorry, but no relevant information or results could be found for your search.

The term appears to be random or without any apparent meaning. Please refine your search or browse through the latest news.

Destination
'Would have been nice to see': Daredevil: Born Again fans are upset about that fatal moment in episode 7 of the hit Marvel TV show

Daredevil: Born Again viewers have reacted negatively to the Marvel TV show's latest character death on Disney+. [...]

Match Score: 0.00

cnet
Tariffs or No, Apple May Raise iPhone Prices This Year

The tech company could increase prices of its next flagship product line, as it introduces a thinner design and new features. [...]

Match Score: 0.00

Destination
Animoca Brands reports a sharp 167% rise in books in Q4 to $108M

Animoca Brands reported Q4 bookings coming in at $108 milliion, up 167% times from $40 million a year ago. [...]

Match Score: 0.00

Destination
TikTok banned #SkinnyTok. That wont stop the disordered eating content.

TikTok banned the hashtag #SkinnyTok for promoting disordered eating, but the toxic content is still easy to find under new names. [...]

Match Score: 0.00

zdnet
Is AI overhyped or underhyped? 6 tips to separate fact from fiction

Two leading authorities on the AI wave disagree on its potential impact. [...]

Match Score: 0.00

Destination
US deportation airline GlobalX website defaced by hackers, data stolen

Anonymous is "enforcing the judge's orders" by defacing GlobalX and stealing passenger manifests. [...]

Match Score: 0.00

Destination
Quordle hints and answers for Thursday, March 20 (game #1151)

Looking for Quordle clues? We can help. Plus get the answers to Quordle today and past solutions. [...]

Match Score: 0.00

Destination
AMD’s FSR 4 upscaling is exclusive to 90-series Radeon GPUs, won’t work on other cards

Like Nvidia, AMD is locking some upscaling advancements to its newest GPUs. [...]

Match Score: 3.00

Destination
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race

Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous with a booming weight loss drug market that could hit $139 billion by 2030.Read more... [...]

Match Score: 0.00